Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Updates on Wuhan 2019 novel coronavirus epidemic

(2020) Foster Kofi Ayittey et al.   JOURNAL OF MEDICAL VIROLOGY

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

(2020) Clark D Russell et al.   LANCET

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

Successful use of methylprednisolone for treating severe COVID-19

(2020) Jing Liu et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19

(2020) Xiaowei Fang et al.   JOURNAL OF INFECTION

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

(2020) Zhaohai Zheng et al.   JOURNAL OF INFECTION

Metformin and COVID‐19: A novel deal of an Old Drug

(2020) Amr Ahmed EL‐Arabey et al.   JOURNAL OF MEDICAL VIROLOGY

Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID‐19 patients under 50 years old

(2020) Yuan Gong et al.   JOURNAL OF MEDICAL VIROLOGY

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis

(2020) Huan Li et al.   LEUKEMIA

Corticosteroid treatment of patients with coronavirus disease 2019 ( COVID ‐19)

(2020) Lei Zha et al.   MEDICAL JOURNAL OF AUSTRALIA

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020

(2020) et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

(2020) Yonggang Zhou et al.   National Science Review

The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities

(2020) Elif Damla Arisan et al.   Viruses-Basel

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19

(2020) Bruno M. Tomazini et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome

(2018) Yaseen M. Arabi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia

(2017) Hui Li et al.   Influenza and Other Respiratory Viruses

Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia

(2015) Reed A.C. Siemieniuk et al.   ANNALS OF INTERNAL MEDICINE

The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome

(2014) K. J. Guo et al.   Bone & Joint Journal

Immunomodulatory therapy for severe influenza

(2011) Ilyse Darwish et al.   Expert Review of Anti-Infective Therapy